Workshop on Connected Devices and Digital Health: How to Navigate the U.S. FDA Usability Engineering Requirements
Our conference co-chair Shannon Clark has conducted numerous workshops on human factors and usability testing throughout the world, from Stockholm to Shanghai. This year’s workshop will discuss the U.S. FDA Human Factors Engineering Process in the context of digital health and connected devices, as well as unique U.S. FDA regulatory hurdles related to this domain.
Running alongside the main conference will be an interactive post-conference workshop on September 15th, 2021 on 'Connected Devices and Digital Health: How to Navigate the U.S. FDA Usability Engineering Requirements'
Why you should attend:
• Review all applications for connected devices
• Discuss the unique U.S. FDA regulatory requirements related to phone applications
• and connected devices
• Discover common software and device development pitfalls related to connected
• devices and digital health
• Walk through the unique considerations for your human factor’s strategy and the
• details of usability testing for Apps and connected devices
Visit the event website to learn more and download the brochure at www.prefilled-sanfrancisco.com/openpr4
Key sessions discussed at workshop:
Session 1: Connected Devices and Digital Health - Current and Future Applications
• What’s the digital health landscape and latest buzz in Silicon Valley, California, as well as the rest of the world?
• What innovations are currently tackling issues of medication adherence, medical product adherence, clinical decision support, and remote patient monitoring?
• How are innovators solving patient needs via user centered design of digital health apps?
Session 2: Overview of applicable U.S. FDA usability engineering requirements & regulatory requirements for connected devices and digital health
• What U.S. FDA Regulations and Guidance do we need to know about when developing connected devices and digital health applications?
• What digital health applications are NOT governed by the U.S. FDA
Session 3: Review unique usability engineering considerations related to connected devices
• Case Study: What are some unique human factors and usability engineering considerations when developing an app and connected device?
• Case Study: What are some best practices and design considerations (i.e. heuristics) to take into account when developing digital health applications and connected devices?
• Looking Ahead: What can we expect in 2029?
Register online: www.prefilled-sanfrancisco.com/openpr4
Early bird offer register by 30th June and save $100
Sponsored by Almac| Boston Analytical | Zeon | ZwickRoell
For all media inquiries contact Jinna Sidhu on Tel: +44 (0)20 7827 6088 / Email: email@example.com
India House, 45 Curlew Street
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Workshop on Connected Devices and Digital Health: How to Navigate the U.S. FDA Usability Engineering Requirements here
News-ID: 2305946 • Views: 421
More Releases from SMi Group
Conference Chair Di Morris, AstraZeneca invites Microbiologists to join SMi's 10 …
SMi Reports: Conference Chair Di Morris, AstraZeneca invites industry experts to attend the 10th Anniversary of Pharmaceutical Microbiology UK Conference taking place in London on 17-18 January 2022. Di Morris invitation to all senior microbiologists write: ‘As chair of SMi's 10th Annual Pharmaceutical Microbiology UK Conference, it is my pleasure to cordially invite you to attend this anticipated must attend conference taking place on 17th and 18th January 2022 in London, UK.’ ‘Microbiology
Leading Microbiologists to meet at SMi’s 10th Annual Pharmaceutical Microbiolo …
SMi Reports: Leading pharmaceutical microbiologists and industry experts to meet at SMi’s 10th Anniversary Pharmaceutical Microbiology UK Conference taking place in London on 17-18 January 2022. SMi Group announces the 10th Annual Pharmaceutical Microbiology UK Conference to take place on the 17 - 18 January 2022 in London. The 10th Anniversary conference theme is “Exploring Robust Risk-Based Microbiological Control Strategy”. The two-day conference will be chaired by Di Morris, Clinical Auditor,
Keynote address from TÜV SÜD and Amgen at Medical Devices and IVD Conference i …
The MDR and IVDR updates will have a profound impact on the medical device industry, bringing certain products into regulatory scope that were previously excluded, introducing new manufacturing requirements, and increasing the burden for post-market surveillance. What does this mean for the future of the Medical Devices and IVD industry? More information on the programme and speaker line-up can be found here: www.medicaldevices-ivd.com/pr3openpr IVDR implementation: State of
Registration Opens for Energy from Waste Conference 2021
SMi Group’s Energy from Waste conference will return to London for its 14th year this December SMi Group are pleased to announce the return of their Energy from Waste conference, which will return to London for its 14th year on 1st – 2nd December 2021. Due to the current political climate, the Energy From Waste industry is changing dramatically. This years, conference agenda will explore how technological innovations and new policy are
More Releases for FDA
FDA Compliant Blood Storage and Preservation
Accsense Monitoring System Automates Data Archive and Alarming CAS DataLoggers provided the temperature alarming and monitoring system to a hospital blood bank looking to replace their old paper chart recorders as they became unreliable and spare parts were harder to find. For proper blood storage and preservation, the lab’s medical units needed to maintain storage temperatures between 2°C to 6°C (36°F to 43°F), given the perishability of blood components. The facility
Peyronie’s Disease Market - Only FDA approved product
The market is dominated by a single player, Endo International plc who sells the only FDA approved Peyronie’s disease product. In May 2015, the American Urological Association presented the first ever treatment guidelines for Peyronie’s disease recommending the use of Xiaflex. Furthermore, the company is creating awareness through its “Ask About the Curve” campaign. Also, reimbursement from the U.S. insurance providers will boost the demand for this product. The product
FDA grants orphan drug status to Vicore
US Food and Drug Administration has awarded Vicore Pharmaceuticals with orphan Drug designation for the treatment of Idiopathic Pulmonary Fibrosis (IPF). FDA’s Orphan Drug Designation program provides certain incentives for companies developing therapeutics to treat rare diseases or conditions, defined as those affecting less than 200,000 individuals in the U.S. A drug candidate and its sponsor must meet several key criteria in order to qualify for, and obtain, orphan drug
New FDA Design Control Training Courses
Salt Lake City, Utah - February 23 2017 - Procenius Consulting is a medical device consulting firm specializing solely in medical device design controls regulation (21 CFR 820.30). Announcing New Design Control Training Courses Procenius Consulting has just launched two new training courses covering basic and advanced topics of medical device design control regulation. These courses focus on compliance, practical implementation and industry best practices techniques for developing or improving a
fda online training
GRC Training Solutions provides end-to-end FDA compliance solutions for those companies who want to maximize security, minimize operational costs, improve staff productivity and stay on top of all their compliance documentation. GRC Training Solutions boasts a team of experts and specialists who have a proven track record in working with the biotechnology, medical device, diagnostic and pharmaceutical fields. Our team will work with you closely and develop solutions that meet
FDA online training
Description: Device firms, establishments or facilities that are involved in the production and distribution of medical devices intended for use in the U.S are required to register annually. Most establishments that are required to register with the FDA are also required to list the devices that are made there and the activities that are performed on those devices. Initially, FDA issued a 28-page Proposed Rule that would amend its regulations regarding